Skip to main content
Top
Published in: BMC Women's Health 1/2021

Open Access 01-12-2021 | Contraception | Research article

Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative study

Authors: Agatha K. Bula, Kendra Hatfield-Timajchy, John Chapola, L. Chinula, Stacey A. Hurst, Athena P. Kourtis, J. H. Tang

Published in: BMC Women's Health | Issue 1/2021

Login to get access

Abstract

Background

Although many countries have been promoting hormonal contraceptives to prevent unintended pregnancy and condom use to prevent HIV transmission, little is known about how women targeted by these messages have interpreted and internalized them. We describe HIV-positive and negative women’s understanding of the benefits of contraception and condoms and their motivations to use them.

Methods

This is a qualitative sub-study from a clinical trial evaluating the effects of progestin contraception on HIV-positive and negative women aged 18–45 years randomly assigned to depot medroxyprogesterone acetate (DMPA) injection or levonorgestrel (LNG) implant. We purposively recruited 41 women to participate in in-depth interviews (IDIs) and focus group discussions (FGDs) after randomization into the main study. We conducted a total of 30 IDIs and 6 FGDs comprised of 4–7 women (N = 32). All women were counselled about potential risks for HIV acquisition/transmission with progestin-only contraception, drug-drug interactions between the implant and efavirenz-based ART, and the need to use condoms with their assigned contraceptive to help prevent pregnancy and HIV acquisition and transmission.

Results

All women understood that HIV is transmitted through unprotected sex and that HIV transmission can be prevented through condom use but not DMPA injection or LNG implant use. Nearly all HIV-positive women knew or suspected that their partners were also HIV-positive and were most interested in using condoms to prevent infection with a drug-resistant HIV strain to keep their HIV viral load low. Almost all reported that their partners agreed to condom use, but few used them consistently. Most women believed that condoms were effective at preventing both HIV and pregnancy if used consistently. Nearly all women considered contraception and condom use as important in preventing unintended pregnancy and HIV because partner disclosure of HIV status is low.

Conclusion

Our results showed that both HIV-positive and negative women understood modes of HIV transmission and prevention and were aware that hormonal contraceptives are only effective for preventing pregnancy and not HIV. Although both HIV-negative and positive women were motivated to use condoms to prevent both HIV acquisition and infection with other HIV strains respectively, they all faced challenges from their partners in using condoms consistently.
Appendix
Available only for authorised users
Footnotes
1
Evidence at the time suggested an interaction for HIV acquisition but that data now show this not to be the case according to the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial. https://​www.​medscape.​com/​viewarticle/​914482
 
2
Use of trade names and commercial sources is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention, the Public Health Service, or the U.S. Department of Health and Human Services.
 
Literature
1.
go back to reference United Nations. The sustainable development goals report 2020. Geneva; 2020. United Nations. The sustainable development goals report 2020. Geneva; 2020.
3.
go back to reference Darroch JE. Adding it up: investing in contraception and maternal and Newborn health, 2017—estimation methodology. New York: Guttmacher Institute; 2018. Darroch JE. Adding it up: investing in contraception and maternal and Newborn health, 2017—estimation methodology. New York: Guttmacher Institute; 2018.
5.
go back to reference Calvert C, Ronsmans C. The contribution of HIV to pregnancy-related mortality: a systematic review and meta-analysis. AIDS. 2013;27(10):1631–9.CrossRef Calvert C, Ronsmans C. The contribution of HIV to pregnancy-related mortality: a systematic review and meta-analysis. AIDS. 2013;27(10):1631–9.CrossRef
6.
go back to reference Lathrop E, Jamieson DJ, Danel I. HIV and maternal mortality. Int J Gynaecol Obstet Off Org Int Fed Gynaecol Obstet. 2014;127(2):213–5.CrossRef Lathrop E, Jamieson DJ, Danel I. HIV and maternal mortality. Int J Gynaecol Obstet Off Org Int Fed Gynaecol Obstet. 2014;127(2):213–5.CrossRef
7.
go back to reference Kendall T, Danel I, Cooper D, et al. Eliminating preventable HIV-related maternal mortality in sub-Saharan Africa: what do we need to know? J Acquir Immune Defic Syndr. 1999;2014(67 Suppl 4):S250-258. Kendall T, Danel I, Cooper D, et al. Eliminating preventable HIV-related maternal mortality in sub-Saharan Africa: what do we need to know? J Acquir Immune Defic Syndr. 1999;2014(67 Suppl 4):S250-258.
9.
go back to reference Sully EABA, Darroch JE, Rile T, Ashford LS, Lince-Deroche N, Firestei L, Murro R. Adding it up: investing in sexual and reproductive health 2019. New York: Guttmacher Institute; 2020.CrossRef Sully EABA, Darroch JE, Rile T, Ashford LS, Lince-Deroche N, Firestei L, Murro R. Adding it up: investing in sexual and reproductive health 2019. New York: Guttmacher Institute; 2020.CrossRef
10.
go back to reference Castle S, Askew I. Contraceptive discontinuation: reasons challenges and solutions; 2016. Castle S, Askew I. Contraceptive discontinuation: reasons challenges and solutions; 2016.
11.
go back to reference Ralph LJ, McCoy SI, Shiu K, Padian NS. Hormonal contraceptive use and women’s risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis. 2015;15(2):181–9.CrossRef Ralph LJ, McCoy SI, Shiu K, Padian NS. Hormonal contraceptive use and women’s risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis. 2015;15(2):181–9.CrossRef
12.
go back to reference Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet. 2019;394(10195):303–13.CrossRef Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet. 2019;394(10195):303–13.CrossRef
13.
go back to reference National Statistical Office (NSO) [Malawi] I. Malawi Demographic and Health Survey 2015–16. Zomba, Malawi, and Rockville, Maryland, USA. NSO and ICF 2017. National Statistical Office (NSO) [Malawi] I. Malawi Demographic and Health Survey 2015–16. Zomba, Malawi, and Rockville, Maryland, USA. NSO and ICF 2017.
14.
go back to reference Tsui AO, Brown W, Li Q. Contraceptive practice in Sub-Saharan Africa. Popul Dev Rev. 2017;43(Suppl 1):166–91.CrossRef Tsui AO, Brown W, Li Q. Contraceptive practice in Sub-Saharan Africa. Popul Dev Rev. 2017;43(Suppl 1):166–91.CrossRef
15.
go back to reference Kourtis AP, Haddad L, Tang J, et al. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: addressing evolving research priorities. Contemp Clin Trials. 2017;52:27–34.CrossRef Kourtis AP, Haddad L, Tang J, et al. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: addressing evolving research priorities. Contemp Clin Trials. 2017;52:27–34.CrossRef
16.
go back to reference Nansseu JR, Nchinda EC, Katte JC, Nchagnouot FM, Nguetsa GD. Assessing the knowledge, attitude and practice of family planning among women living in the Mbouda health district. Cameroon Reprod Health. 2015;12:92.CrossRef Nansseu JR, Nchinda EC, Katte JC, Nchagnouot FM, Nguetsa GD. Assessing the knowledge, attitude and practice of family planning among women living in the Mbouda health district. Cameroon Reprod Health. 2015;12:92.CrossRef
17.
go back to reference Bryant AG, Hamela G, Gotter A, Stuart GS, Kamanga G. Reasons for intrauterine device use, discontinuation and non-use in malawi: a qualitative study of women and their partners. Afr J Reprod Health. 2015;19(4):50–7.PubMed Bryant AG, Hamela G, Gotter A, Stuart GS, Kamanga G. Reasons for intrauterine device use, discontinuation and non-use in malawi: a qualitative study of women and their partners. Afr J Reprod Health. 2015;19(4):50–7.PubMed
18.
go back to reference Mekonnen H, Enquselassie F. Effect of antiretroviral therapy on changes in the fertility intentions of human immunodeficiency virus-positive women in Addis Ababa, Ethiopia: a prospective follow-up study. Epidemiol Health. 2017;39:e2017028.CrossRef Mekonnen H, Enquselassie F. Effect of antiretroviral therapy on changes in the fertility intentions of human immunodeficiency virus-positive women in Addis Ababa, Ethiopia: a prospective follow-up study. Epidemiol Health. 2017;39:e2017028.CrossRef
19.
go back to reference Salters K, Loutfy M, de Pokomandy A, et al. Pregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada. PLoS ONE. 2017;12(7):e0180524.CrossRef Salters K, Loutfy M, de Pokomandy A, et al. Pregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada. PLoS ONE. 2017;12(7):e0180524.CrossRef
20.
go back to reference Schwartz SR, Mehta SH, Taha TE, Rees HV, Venter F, Black V. High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy. AIDS Behav. 2012;16(1):69–78.CrossRef Schwartz SR, Mehta SH, Taha TE, Rees HV, Venter F, Black V. High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy. AIDS Behav. 2012;16(1):69–78.CrossRef
21.
go back to reference Tai JH, Udoji MA, Barkanic G, et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis. 2007;196(7):1044–52.CrossRef Tai JH, Udoji MA, Barkanic G, et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis. 2007;196(7):1044–52.CrossRef
22.
go back to reference Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reproduct Immunol (New York NY 1989). 2010;63(6):425–33.CrossRef Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reproduct Immunol (New York NY 1989). 2010;63(6):425–33.CrossRef
23.
go back to reference Haddad LB, Tang JH, Krashin J, et al. Factors associated with condom use among men and women living with HIV in Lilongwe, Malawi: a cross-sectional study. BMJ Sex Reprod Health. 2018;44(1):1–12.CrossRef Haddad LB, Tang JH, Krashin J, et al. Factors associated with condom use among men and women living with HIV in Lilongwe, Malawi: a cross-sectional study. BMJ Sex Reprod Health. 2018;44(1):1–12.CrossRef
24.
go back to reference Chimbiri AM. The condom is an “intruder” in marriage: evidence from rural Malawi. Soc Sci Med. 2007;64(5):1102–15.CrossRef Chimbiri AM. The condom is an “intruder” in marriage: evidence from rural Malawi. Soc Sci Med. 2007;64(5):1102–15.CrossRef
25.
go back to reference Clark S, Poulin M, Kohler HP. marital aspirations, sexual behaviors, and HIV/AIDS in rural Malawi. J Marriage Fam. 2009;71(2):396–416.CrossRef Clark S, Poulin M, Kohler HP. marital aspirations, sexual behaviors, and HIV/AIDS in rural Malawi. J Marriage Fam. 2009;71(2):396–416.CrossRef
26.
go back to reference John NA, Babalola S, Chipeta E. Sexual pleasure, partner dynamics and contraceptive use in Malawi. Int Perspect Sex Reprod Health. 2015;41(2):99–107.CrossRef John NA, Babalola S, Chipeta E. Sexual pleasure, partner dynamics and contraceptive use in Malawi. Int Perspect Sex Reprod Health. 2015;41(2):99–107.CrossRef
27.
go back to reference Randolph ME, Pinkerton SD, Bogart LM, Cecil H, Abramson PR. Sexual pleasure and condom use. Arch Sex Behav. 2007;36(6):844–8.CrossRef Randolph ME, Pinkerton SD, Bogart LM, Cecil H, Abramson PR. Sexual pleasure and condom use. Arch Sex Behav. 2007;36(6):844–8.CrossRef
28.
go back to reference Agunbiade OM, Togunde D. “No sweet in sex”: perceptions of condom usefulness among elderly Yoruba people in Ibadan Nigeria. J Cross Cult Gerontol. 2018;33(3):319–36.CrossRef Agunbiade OM, Togunde D. “No sweet in sex”: perceptions of condom usefulness among elderly Yoruba people in Ibadan Nigeria. J Cross Cult Gerontol. 2018;33(3):319–36.CrossRef
29.
go back to reference Moore L, Beksinska M, Rumphs A, Festin M, Gollub EL. Knowledge, attitudes, practices and behaviors associated with female condoms in developing countries: a scoping review. Open Access J Contracept. 2015;6:125–42.CrossRef Moore L, Beksinska M, Rumphs A, Festin M, Gollub EL. Knowledge, attitudes, practices and behaviors associated with female condoms in developing countries: a scoping review. Open Access J Contracept. 2015;6:125–42.CrossRef
30.
go back to reference Montgomery ET, van der Straten A, Chitukuta M, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31(8):1159–67.CrossRef Montgomery ET, van der Straten A, Chitukuta M, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31(8):1159–67.CrossRef
31.
go back to reference Seidman D, Weber S, Aaron E. Dapivirine vaginal ring for HIV-1 prevention. N Engl J Med. 2017;376(10):995.PubMed Seidman D, Weber S, Aaron E. Dapivirine vaginal ring for HIV-1 prevention. N Engl J Med. 2017;376(10):995.PubMed
32.
go back to reference Atujuna M, Newman PA, Wallace M, et al. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: a qualitative study. PLoS ONE. 2018;13(2):e0191251.CrossRef Atujuna M, Newman PA, Wallace M, et al. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: a qualitative study. PLoS ONE. 2018;13(2):e0191251.CrossRef
33.
go back to reference Baeten JM, Donnell D, Mugo NR, et al. Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2014;14(11):1055–64.CrossRef Baeten JM, Donnell D, Mugo NR, et al. Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2014;14(11):1055–64.CrossRef
34.
go back to reference Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRef Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRef
35.
go back to reference Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRef Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRef
36.
go back to reference Hsu DC, O’Connell RJ. Progress in HIV vaccine development. Hum Vaccines Immunother. 2017;13(5):1018–30.CrossRef Hsu DC, O’Connell RJ. Progress in HIV vaccine development. Hum Vaccines Immunother. 2017;13(5):1018–30.CrossRef
37.
go back to reference Mboane R, Bhatta MP. Influence of a husband’s healthcare decision making role on a woman’s intention to use contraceptives among Mozambican women. Reprod Health. 2015;12:36.CrossRef Mboane R, Bhatta MP. Influence of a husband’s healthcare decision making role on a woman’s intention to use contraceptives among Mozambican women. Reprod Health. 2015;12:36.CrossRef
38.
go back to reference Ezeanolue EE, Iwelunmor J, Asaolu I, et al. Impact of male partner’s awareness and support for contraceptives on female intent to use contraceptives in southeast Nigeria. BMC Public Health. 2015;15:879.CrossRef Ezeanolue EE, Iwelunmor J, Asaolu I, et al. Impact of male partner’s awareness and support for contraceptives on female intent to use contraceptives in southeast Nigeria. BMC Public Health. 2015;15:879.CrossRef
39.
go back to reference Prata N, Bell S, Fraser A, Carvalho A, Neves I, Nieto-Andrade B. Partner support for family planning and modern contraceptive use in Luanda, Angola. Afr J Reprod Health. 2017;21(2):35–48.CrossRef Prata N, Bell S, Fraser A, Carvalho A, Neves I, Nieto-Andrade B. Partner support for family planning and modern contraceptive use in Luanda, Angola. Afr J Reprod Health. 2017;21(2):35–48.CrossRef
40.
go back to reference Apanga PA, Adam MA. Factors influencing the uptake of family planning services in the Talensi District, Ghana. Pan Afr Med J. 2015;20:10.CrossRef Apanga PA, Adam MA. Factors influencing the uptake of family planning services in the Talensi District, Ghana. Pan Afr Med J. 2015;20:10.CrossRef
Metadata
Title
Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative study
Authors
Agatha K. Bula
Kendra Hatfield-Timajchy
John Chapola
L. Chinula
Stacey A. Hurst
Athena P. Kourtis
J. H. Tang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2021
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01236-1

Other articles of this Issue 1/2021

BMC Women's Health 1/2021 Go to the issue